JTK 109
Alternative Names: JTK-109Latest Information Update: 06 Oct 2003
At a glance
- Originator Japan Tobacco
- Class
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 06 Oct 2003 Discontinued - Phase-I for Hepatitis C (PO)
- 06 Oct 2003 Discontinued - Phase-I for Hepatitis C in Japan (PO)
- 02 Dec 2002 Phase-I clinical trials in Hepatitis C (PO)